{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:31:34Z","timestamp":1773887494559,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to assess the association between fasting triglyceride (FTG) levels and the prevalence of asymptomatic intracranial arterial stenosis (ICAS). The Asymptomatic Polyvascular Abnormalities Community (APAC) study is a sub-population of the Kailuan study which targeting on the epidemiology of asymptomatic polyvascular abnormalities in Chinese adults. A total number of 5345 participants, aged \u226540, and without history of stroke, transient ischemic attack, and coronary heart disease were enrolled in this study. Transcranial Doppler Ultrasonography was performed for the detection of ICAS presence. Out of 5345 participants, 698 subjects diagnosed ICAS (13.1%). In univariate analysis, the association between fasting TG (FTG) levels and asymptomatic ICAS didn\u2019t reach statistical significance (OR: 0.99, 95% CI: 0.89\u20131.09; P\u2009=\u20090.79), the same conclusion was reached in multivariate analysis, after adjustment for age, sex (OR: 1.05, 95% CI: 0.95\u20131.17) and age, sex, current smoking status, hypertension, diabetes, body mass index, estimated glomerular filtration rate, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol (OR: 0.95, 95% CI: 0.84\u20131.06), respectively. FTG failed to show any statistical significance on ICAS presence in the APAC study, but the TG actually plays an important role in the progression of atherosclerosis as a biomarker.<\/jats:p>","DOI":"10.1038\/s41598-018-24157-w","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T15:00:45Z","timestamp":1523458845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Association between fasting Triglyceride levels and the Prevalence of Asymptomatic Intracranial Arterial Stenosis in a Chinese Community-based Study"],"prefix":"10.1038","volume":"8","author":[{"given":"Jianwei","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anxin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8345-5147","authenticated-orcid":false,"given":"Xingquan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"24157_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/ene.12385","volume":"21","author":"V Battistella","year":"2014","unstructured":"Battistella, V. & Elkind, M. Intracranial atherosclerotic disease. Eur J Neurol 21, 956\u2013962 (2014).","journal-title":"Eur J Neurol"},{"key":"24157_CR2","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/S1474-4422(13)70195-9","volume":"12","author":"CA Holmstedt","year":"2013","unstructured":"Holmstedt, C. A., Turan, T. N. & Chimowitz, M. I. Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment. Lancet neurology 12, 1106\u20131114 (2013).","journal-title":"Lancet neurology"},{"issue":"1","key":"24157_CR3","doi-asserted-by":"publisher","first-page":"11S","DOI":"10.1111\/j.1552-6569.2009.00415.x","volume":"19","author":"MF Suri","year":"2009","unstructured":"Suri, M. F. & Johnston, S. C. Epidemiology of intracranial stenosis. Journal of neuroimaging: official journal of the American Society of Neuroimaging 19(1), 11S\u201316S (2009).","journal-title":"Journal of neuroimaging: official journal of the American Society of Neuroimaging"},{"key":"24157_CR4","doi-asserted-by":"publisher","first-page":"e80675","DOI":"10.1371\/journal.pone.0080675","volume":"8","author":"YF Sung","year":"2013","unstructured":"Sung, Y. F. et al. Reversal of ophthalmic artery flow and stroke outcomes in Asian patients with acute ischemic stroke and unilateral severe cervical carotid stenosis. PLoS One 8, e80675 (2013).","journal-title":"PLoS One"},{"key":"24157_CR5","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1161\/STROKEAHA.110.584672","volume":"41","author":"TN Turan","year":"2010","unstructured":"Turan, T. N. et al. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke 41, 1636\u20131640 (2010).","journal-title":"Stroke"},{"key":"24157_CR6","doi-asserted-by":"publisher","first-page":"1K","DOI":"10.1016\/j.amjcard.2008.10.002","volume":"102","author":"J-C Fruchart","year":"2008","unstructured":"Fruchart, J.-C. et al. The Residual Risk Reduction Initiative: A Call to Action to Reduce Residual Vascular Risk in Patients with Dyslipidemia. The American journal of cardiology 102, 1K\u201334K (2008).","journal-title":"The American journal of cardiology"},{"key":"24157_CR7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.numecd.2013.05.002","volume":"23","author":"\u017d Reiner","year":"2013","unstructured":"Reiner, \u017d. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update. Nutrition, Metabolism and Cardiovascular Diseases 23, 799\u2013807 (2013).","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"key":"24157_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11883-011-0219-7","volume":"14","author":"UK Sampson","year":"2012","unstructured":"Sampson, U. K., Fazio, S. & Linton, M. F. Residual Cardiovascular Risk Despite Optimal LDL-Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges. Current atherosclerosis reports 14, 1\u201310 (2012).","journal-title":"Current atherosclerosis reports"},{"key":"24157_CR9","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"M Miller","year":"2011","unstructured":"Miller, M. et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292\u20132333 (2011).","journal-title":"Circulation"},{"key":"24157_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard, B. G., Benn, M., Schnohr, P. & Tybj\u00e6rg-Hansen, A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299\u2013308 (2007).","journal-title":"JAMA"},{"key":"24157_CR11","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/jama.2008.621","volume":"300","author":"JJ Freiberg","year":"2008","unstructured":"Freiberg, J. J., Tybj\u00e6rg-Hansen, A., Jensen, J. & Nordestgaard, B. G. Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300, 2142\u20132152 (2008).","journal-title":"JAMA"},{"key":"24157_CR12","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1161\/01.CIR.0000145542.24347.18","volume":"110","author":"A Patel","year":"2004","unstructured":"Patel, A. et al. Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region. Circulation 110, 2678\u20132686 (2004).","journal-title":"Circulation"},{"key":"24157_CR13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","volume":"115","author":"N Sarwar","year":"2007","unstructured":"Sarwar, N. et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115, 450\u2013458 (2007).","journal-title":"Circulation"},{"key":"24157_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2337\/dc08-1543","volume":"32","author":"R Scott","year":"2009","unstructured":"Scott, R. et al. Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes care 32, 493\u2013498 (2009).","journal-title":"Diabetes care"},{"key":"24157_CR15","first-page":"1943","volume":"371","author":"MJ Landray","year":"2014","unstructured":"Landray, M. J., Haynes, R. & Armitage, J. Niacin for reduction of cardiovascular risk. N Engl J Med 371, 1943\u20131944 (2014).","journal-title":"N Engl J Med"},{"key":"24157_CR16","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1016\/S0140-6736(07)60527-3","volume":"369","author":"M Yokoyama","year":"2007","unstructured":"Yokoyama, M. et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. The Lancet 369, 1090\u20131098 (2007).","journal-title":"The Lancet"},{"key":"24157_CR17","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/ng.2795","volume":"45","author":"R Do","year":"2013","unstructured":"Do, R. et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nature genetics 45, 1345\u20131352 (2013).","journal-title":"Nature genetics"},{"key":"24157_CR18","unstructured":"J. Brunzell, S. Deeb Familial lipoprotein lipase deficiency, apoC-II deficiency, and hepatic lipase deficiency. (2001)."},{"key":"24157_CR19","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1016\/j.jacc.2014.09.042","volume":"64","author":"RS Rosenson","year":"2014","unstructured":"Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S. & Gaudet, D. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease. Journal of the American College of Cardiology 64, 2525 (2014).","journal-title":"Journal of the American College of Cardiology"},{"key":"24157_CR20","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1126\/science.1161524","volume":"322","author":"TI Pollin","year":"2008","unstructured":"Pollin, T. I. et al. A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection. Science (New York, NY) 322, 1702\u20131705 (2008).","journal-title":"Science (New York, NY)"},{"key":"24157_CR21","first-page":"70","volume":"119","author":"S Romeo","year":"2009","unstructured":"Romeo, S. et al. Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans. The Journal of Clinical Investigation 119, 70\u201379 (2009).","journal-title":"The Journal of Clinical Investigation"},{"key":"24157_CR22","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","volume":"45","author":"CJ Willer","year":"2013","unstructured":"Willer, C. J. et al. Discovery and Refinement of Loci Associated with Lipid Levels. Nature genetics 45, 1274\u20131283 (2013).","journal-title":"Nature genetics"},{"key":"24157_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ajhg.2014.01.009","volume":"94","author":"GM Peloso","year":"2014","unstructured":"Peloso, G. M. et al. Association of Low-Frequency and Rare Coding-Sequence Variants with Blood Lipids and Coronary Heart Disease in 56,000 Whites and Blacks. American Journal of Human Genetics 94, 223\u2013232 (2014).","journal-title":"American Journal of Human Genetics"},{"key":"24157_CR24","first-page":"309","volume":"298","author":"S Bansal","year":"2007","unstructured":"Bansal, S. et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Digest of the World Core Medical Journals 298, 309\u2013316 (2007).","journal-title":"Digest of the World Core Medical Journals"},{"key":"24157_CR25","first-page":"490","volume":"153","author":"H Iso","year":"2001","unstructured":"Iso, H. et al. Nonfasting serum triglycerides and risk of ischemic heart disease among Japanese men and women. International Congress 153, 490 (2001).","journal-title":"International Congress"},{"key":"24157_CR26","first-page":"e384","volume":"119","author":"S Mora","year":"2009","unstructured":"Mora, S., Rifai, N., Buring, J. E. & Ridker, P. M. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events. Circulation 119, e384, author replye 385 (2009).","journal-title":"Circulation"},{"key":"24157_CR27","first-page":"299","volume":"298","author":"BG Nordestgaard","year":"2007","unstructured":"Nordestgaard, B. G., Benn, M., Schnohr, P. & Tybj\u00e6rghansen, A. Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women. Digest of the World Core Medical Journals 298, 299\u2013308 (2007).","journal-title":"Digest of the World Core Medical Journals"},{"key":"24157_CR28","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1210\/jc.2011-3213","volume":"97","author":"L Berglund","year":"2012","unstructured":"Berglund, L. et al. Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism 97, 2969\u20132989 (2012).","journal-title":"Journal of Clinical Endocrinology & Metabolism"},{"key":"24157_CR29","unstructured":"M. Authors\/TaskForce et al. 2016 ESC\/EAS Guidelines for the Management of Dyslipidaemias: The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS) Developed with the special contribution of the European Assocciation for Cardiovascular Prevention & Rehabilitation (EACPR). Atherosclerosis 253, 281\u2013344 (2016)."},{"key":"24157_CR30","doi-asserted-by":"crossref","unstructured":"Leonards, C. The role of fasting versus non-fasting triglycerides in ischemic stroke: a systematic review. Frontiers in Neurology 1 (2010).","DOI":"10.3389\/fneur.2010.00133"},{"key":"24157_CR31","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2008.08.040","volume":"203","author":"J Labreuche","year":"2009","unstructured":"Labreuche, J., Touboul, P. J. & Amarenco, P. Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis 203, 331\u2013345 (2009).","journal-title":"Atherosclerosis"},{"key":"24157_CR32","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1161\/hs1101.098520","volume":"32","author":"FP D\u2019Armiento","year":"2001","unstructured":"D\u2019Armiento, F. P. et al. Age-related effects on atherogenesis and scavenger enzymes of intracranial and extracranial arteries in men without classic risk factors for atherosclerosis. Stroke 32, 2472\u20132479 (2001).","journal-title":"Stroke"},{"key":"24157_CR33","doi-asserted-by":"publisher","first-page":"e65229","DOI":"10.1371\/journal.pone.0065229","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu, J. et al. Association between non-high-density-lipoprotein-cholesterol levels and the prevalence of asymptomatic intracranial arterial stenosis. PLoS One 8, e65229 (2013).","journal-title":"PLoS One"},{"key":"24157_CR34","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1053\/j.ajkd.2011.02.393","volume":"58","author":"BW Teo","year":"2011","unstructured":"Teo, B. W. et al. GFR estimating equations in a multiethnic Asian population. American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation 58, 56\u201363 (2011).","journal-title":"American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation"},{"key":"24157_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1159\/000448309","volume":"40","author":"VK Sharma","year":"2016","unstructured":"Sharma, V. K., Wong, K. S. & Alexandrov, A. V. Transcranial Doppler. Frontiers of Neurology & Neuroscience 40, 124 (2016).","journal-title":"Frontiers of Neurology & Neuroscience"},{"key":"24157_CR36","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1111\/j.1552-6569.2002.tb00123.x","volume":"12","author":"S Gao","year":"2002","unstructured":"Gao, S., Lam, W. W., Chan, Y. L., Liu, J. Y. & Wong, K. S. Optimal values of flow velocity on transcranial Doppler in grading middle cerebral artery stenosis in comparison with magnetic resonance angiography. Journal of Neuroimaging 12, 213 (2002).","journal-title":"Journal of Neuroimaging"}],"updated-by":[{"DOI":"10.1038\/s41598-019-42890-8","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24157-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24157-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:12:40Z","timestamp":1671595960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24157-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24157"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24157-w","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-019-42890-8","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"4 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"5744"}}